All Business And Other Matter
Today marks Buffer’s 12th anniversary. For the occasion, I thought it would be fun to ask my teammates about their favorite memories, stories, and lessons from working at Buffer over the last twelve years. I had them share one favorite story or memory and answer one question about Buffer’s impact on their lives and how […]
Continue ReadingMoney is tight for many individuals and businesses right now, with inflation at historic highs and pressures on the economy coming from multiple directions at once, from the lingering effects of the pandemic to shipping disruptions and the Ukraine war. Two – Two Despite the challenges, there is good news: it is possible to make […]
Continue ReadingThe new year is almost upon us, and one idea for where to invest is the banking sector, whose margins benefit from the high interest rates, at not terribly demanding valuations. That claim may surprise those who think the US banking industry has about $2.2 trillion in capital. But he reduces that figure in several […]
Continue ReadingA team is only as strong as its weakest link. And if the weak link is a team manager, that’s a setup that will kill success before it starts. But a strong and respected manager can help teams work together, thrive and achieve results on an individual and collective level. If you want to become […]
Continue ReadingHere’s one thing most of us agree on…creating content is time consuming. Last month I talked to a bunch of Buffer fans and found that 71 percent wanted a faster way to create and publish content. After hearing this, I decided to crack down on the numbers behind content creation. The average Buffer user publishes […]
Continue ReadingThe two-pronged axis of employee-sponsored pension plans and individual retirement accounts is the stage where, for most Americans, the majority of retirement planning happens. Within that framework, Roth IRAs are renowned for their unparalleled ability to secure tax-free growth. Due – Due But there is a catch – contribution limits and restrictions on high-income individuals […]
Continue ReadingNico El Nino G1 Therapeutics (NASDAQ: GTHX) sells Cosela or trilaciclib, a myelosuppressant drug that was approved in February 2021 as an adjunct to chemotherapy in later stage small cell lung cancer (ES-SCLC, extended stage small cell lung cancer) patients. Unlike other myeloprotective agents that are lineage-specific, trilaciclib protects against chemotherapy patients of all three […]
Continue ReadingWe’ve all heard the saying “you only get one chance to make a first impression.” Well, when it comes to choosing a life insurance plan, you want to make sure you make a good first impression. You don’t want to leave anything up in the air or have any questions about what’s going on with […]
Continue ReadingOpinions expressed by Entrepreneur contributors are their own. It’s the best shopping time of the year, and we’re already releasing doorbuster deals throughout the month of November. But with these limited time deals, you have to act fast because they won’t last long. StackCommerce Entrepreneurs looking to invest in their personal and professional development in […]
Continue Reading“ “How did this guy steal billions of dollars and now speak at a summit as a free man? Make it make sense.” “ It was Twitter user @WSBVoorsitter responding to a late Wednesday tweet by disgraced FTX founder Sam Bankman-Fried, who confirmed that he will participate in the New York Times’ DealBook Summit in […]
Continue Reading